Olgun Yucel, Sencan Savas, Unver Sena, Osmanli Nuride, Kokar Serdar, Gunduz Osman Hakan
Division of Pain Medicine, Department of Physical Medicine and Rehabilitation, Agri Training and Research Hospital, Agri, Turkey.
Division of Pain Medicine, Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Marmara University, Istanbul, Turkey.
Pain Pract. 2025 Apr;25(4):e70024. doi: 10.1111/papr.70024.
To assess the influence of contrast material distribution patterns on treatment success in patients with chronic coccygodynia undergoing ganglion impar block (GIB).
An evaluation was conducted on 58 patients who underwent GIB from August 2021 to August 2023 at a university hospital's interventional pain management center. Numeric rating scale (NRS) scores were recorded before the procedure and at 1-month post-procedure. The patients were categorized into two groups based on treatment success, defined as at least a 50% reduction in the NRS score at 1 month.
There were no significant differences between the two groups regarding age, gender, BMI, symptom duration, comorbidities, coccyx curvature type, presence of anterior/posterior subluxation, presence of posterior spicule, type of approach, contrast distribution direction, and contrast dye level. Patients with coccygodynia experienced statistically significant benefits from GIB treatment at the 1-month follow-up (p < 0.001).
Although the use of contrast material in fluoroscopic procedures is the gold standard to prevent possible complications, the distribution pattern of contrast does not significantly affect the success of GIB treatment in patients with coccygodynia. Further prospective and long-term follow-up studies are required to validate these findings.
评估造影剂分布模式对接受奇神经节阻滞(GIB)治疗的慢性尾骨痛患者治疗效果的影响。
对2021年8月至2023年8月在某大学医院介入疼痛管理中心接受GIB治疗的58例患者进行评估。在手术前和术后1个月记录数字评分量表(NRS)评分。根据治疗效果将患者分为两组,治疗效果定义为术后1个月NRS评分至少降低50%。
两组在年龄、性别、体重指数、症状持续时间、合并症、尾骨弯曲类型、前后半脱位情况、后骨棘情况、手术入路类型、造影剂分布方向和造影剂水平方面无显著差异。尾骨痛患者在1个月随访时GIB治疗有统计学意义的获益(p<0.001)。
尽管在荧光透视手术中使用造影剂是预防可能并发症的金标准,但造影剂的分布模式对尾骨痛患者GIB治疗的成功率没有显著影响。需要进一步的前瞻性和长期随访研究来验证这些发现。